Antithrombin III and the nephrotic syndrome.

Area of Science:

• Nephrology
• Hematology
• Biochemistry

Background:

• Nephrotic syndrome is characterized by heavy proteinuria and potential complications like hypercoagulability.
• Antithrombin III (AT-III) is a key anticoagulant protein.
• Understanding AT-III's role in nephrotic syndrome is crucial for managing thrombotic risks.

Observation:

• Fifteen nephrotic syndrome patients were studied for plasma and urinary antithrombin III (AT-III) levels.
• Plasma AT-III levels correlated with serum albumin but not proteinuria.
• Urinary AT-III excretion showed a strong correlation with proteinuria.

Findings:

• Plasma AT-III levels in nephrotic patients had a wider range compared to healthy controls.
• Urinary AT-III output increased, and plasma levels decreased with rising disease activity.
• Despite similar molecular weights, AT-III and albumin exhibited different renal clearance patterns.

Implications:

• Urinary loss of AT-III is a significant factor in nephrotic syndrome.
• Increased urinary AT-III excretion may contribute to the hypercoagulable state observed in some nephrotic patients.
• This finding suggests potential therapeutic targets for preventing thrombosis in nephrotic syndrome.